ArriVent BioPharma, Inc.
AVBPBiotechnology
$14.87−6.77%As of Oct 30vs prior close
- Market cap
- $733.2M
- P/E (TTM)
- –
- From 52W high
- −57.20%
- EPS (LTM)
- -$3.53
- Dividend yield
- 0.00%
Nomior Score
52
Steady ProfileSpeculativeTop 45% of the scored universe
Growth—
Quality46
Value—
Momentum74
Resilience41
Connections
Who owns it
2funds, 1 tracked portfolio